The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1257
ISSUE 1257
March 26, 2007
Issue 1257
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Once-Daily Mesalamine (Lialda) for Ulcerative Colitis
March 26, 2007 (Issue: 1257)
A once-daily oral formulation of mesalamine (Lialda - Shire) was recently approved by the FDA for induction of remission in patients with mild to moderate ulcerative colitis.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.